Elevance beats expectations with quarterly profit, revenue

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

nifaytnilpdl is-aanrervrl- c.I ein.seh ttioloirn8tueeerdniailWrsa-geursd graynpH alsb raest nu.lbeeaafsor yE dnne oaltdn ocdIei en q fofdaea$p1dcai

ysnrial, t6oirfr1aqdep eoi 1 rrorttaf b-ene $ismf,,olee1 eaedri8. hraushgdp $htpsheii6sng iilrranroal pe oron rr ee8e9hselhr$b. oi ..cr ae noo 7r $ , f2uot r hTnl fw t

sks gis vomuae,a2l ah. -rairteeScia0ts s6alrxdnbonreaca1 ffnRmsdstomunvn itynjtfetet osTte8nrna1oeat iwse cnpsogsanradZhfxes1r.maaW aairea5ioEs$ei ee7st gr.epee ee t r s eInp dc,antyeya v h.l,f ee$ e8 h gees grrac crntdes

le u $soaliasb.rneaubeib p r4e i4lnu Eh$evnasellu eryiad v0cfiae ygndl4 . a wnie4cibo oen1fIxlhe nntxiseu e dnsnZb orev.sre5itSe te ktryniicjtorceed s 9,7.ae9i.n.tsoe oedt8tt$l sbve7 vugpn

icfrehbi Msyo0o0lbedai a 2 .s l -o smoe fm14 mclr5tr5rno0 ifed04ro3aae2 sa8mad mupen 1ceMfah enri, 6kn .a

secshs $gee-l ya arceraaenl27fi. vupuiiE na eanrr dn.ltedr e5g6o

ri tscvteddyc fbixue tcrwe tG iy a ioaigmn nedislrsnp uvxkdahectreael i grr rnt rv dOn.rtcdt tO lmreaerfeincensraoertoe onaoepmi svsya ioecbatlntggo”grepat eubdearcnae iyrovuErehcsc ful axiburerym eh osoeslEuee ea e fr ssetEier tcjgsrua-g p e eissfoir. se ediinttBf oorrSrlne. maiavqWdncleoitie eiepsnro g xa am iu”enuaeur nprt“eii sueuhloe hme ttnimdPi,,dpaiadr l e nceninatnvs ierntvanlHtuxd sct"oilnet,puninfnceeie

tt7anse %lacesh$ 0cwmhi,ne y 3l aa a3r.st h esdeaopv.e re31uEd

Please enable JavaScript to view this content.

1 Comment

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. Definitely not a correlation to increased profits and increased insurance denials…nothing to see here…procedures with a long track record of clinical efficacy being denied with the reason of being it “experimental”.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In